( News links at the bottom ) 

Ministry likes to say there are MANY drugs just as “Clinically Effective” as Ocrevus & Kesimpta available here in BC, But the TRUTH? 

Ocrevus & Kesimpta Aren’t “Just Like” Other MS Drugs…..  

We keep hearing them repeat this over & over.. I am also hearing “There are lots of MS medications”
or “They’re all about the same.”
But that’s just not true, at least not for people like me & SOO many others here in B.C.
MS medications are not a one size fits all! 
Not all target the immune system in the same way! Many of us rely solely on highly-effective Anti-CD20 therapies! 

When you have aggressive, atypical, or slowly progressing MS, it’s not enough to just reduce relapses. You need a drug that targets the immune cells actually driving silent damage in your brain, spinal cord, and optic nerves, along with that ACTIVE aggressive damage. That’s where anti-CD20 therapies come in for a huge population of RRMS patients.

What are anti-CD20 therapies?

These medications go after certain B cells, immune cells that cause:
•optic nerve damage
•spinal cord injury/lesions 
•brain atrophy/lesions 
•disease progression that can happen even when MRIs look “stable”

The main anti-CD20 options are:
•Ocrevus
•Kesimpta
•Rituximab (off-label)
•Briumvi (not approved in Canada)

They all hit the same immune pathway but they’re not equal when it comes to safety, consistency, or long-term outcomes.

Why Ocrevus & Kesimpta stand apart

These two drugs were made specifically for MS, and it shows. They are Humanized monoclonal anti-CD20 therapies :
•Are less likely to trigger immune reactions
•Work in a more predictable way
•Reduce relapses and slow invisible progression
•Have the strongest long-term data for MS

They also come with:
•Fewer infusion/injection reactions
•Lower risk of antibodies that stop the drug from working
•More stable long-term disease control

Kesimpta - FULLY humanized - even comes as a home injection, which makes it easier to tolerate and lowers immune reactions even more.

What about Rituximab?

Rituximab ( A chimeric - derived from mouse antibodies ) also targets CD20 but it wasn’t made for MS. It was designed for cancer and rheumatoid arthritis. 
Rituximab may work for many patients - again I say it wouldn’t be an approved off label medication if it didn’t - BUT for MS patients, that means:
•More infusion reactions ( due to the mouse protien/antibodies ) 
•More immune system disruption ( due to the mouse protien/antibodies ) 
•Higher chance of developing antibodies ( due to the mouse protien/antibodies ) 
•More breakthrough disease compared to Ocrevus & Kesimpta

It’s often chosen because it’s cheaper not because it’s better.

And Briumvi?

Briumvi is another anti-CD20 therapy but here’s the thing:
It’s not approved or available in Canada.
So while it exists on paper, it’s not an option for people like me here.

Are these drugs “equal”?

Only in the sense that they all target B cells.
But in reality:
•They’re not equal in safety
•Not equal in tolerability
•Not equal in durability
•Not equal in long-term protection from disability

When a neurologist says you need high-efficacy anti-CD20 therapy with lower risks, what they usually mean is:  not a cheaper substitute.

Why this matters

For people like me with progression-prone MS, optic nerve damage, spinal cord involvement, or slow worsening even without relapses….. this isn’t about convenience.

It’s about protecting my brain,my spine, my vision, and my future function.

Swapping in a less stable or less tolerated drug can lead to:
•more relapses
•more disability
•more infections
•more hospitalizations
•more loss of vision, mobility, and independence

And once that damage happens? There’s no undo button.

Please keep sharing - I know it seems redundant to many but please know this matters hugely to us BC MS Warriors, thank you everyone from the bottom of my heart for all your support!! I dont think Iv had a dry eye this week! 

https://globalnews.ca/video/11608025/ms-patient-calling-out-systematic-failures-in-b-c-drug-coverage/

https://www.ctvnews.ca/vancouver/article/woman-pleads-for-bc-government-to-cover-multiple-sclerosis-drug/